Eloxx Pharmaceuticals, Inc. Insider Trading for June 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Eloxx Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Eloxx Pharmaceuticals, Inc. for June 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29 2018 | ELOX | Eloxx Pharmaceutic ... | Noiman Silvia | Chief Executive Off ... | Option Exercise | M | 0.00 | 349,400 | 210 | 0 | |
| Jun 29 2018 | ELOX | Eloxx Pharmaceutic ... | Noiman Silvia | Chief Executive Off ... | Buy | M | 0.00 | 349,400 | 210 | 490,789 | 141.4 K to 490.8 K (+247.12 %) |
| Jun 26 2018 | ELOX | Eloxx Pharmaceutic ... | Williams Gregory C. | Chief Operating Off ... | Option Exercise | A | 18.84 | 300,000 | 5,652,000 | 300,000 | |
| Jun 26 2018 | ELOX | Eloxx Pharmaceutic ... | Snow David P. | Chief Business Offi ... | Option Exercise | A | 18.85 | 200,000 | 3,770,000 | 200,000 | |
| Jun 26 2018 | ELOX | Eloxx Pharmaceutic ... | Williams Gregory C. | Chief Operating Off ... | Option Exercise | A | 18.84 | 300,000 | 5,652,000 | 300,000 | |
| Jun 26 2018 | ELOX | Eloxx Pharmaceutic ... | Snow David P. | Chief Business Offi ... | Option Exercise | A | 18.85 | 200,000 | 3,770,000 | 200,000 | |
| Jun 20 2018 | ELOX | Eloxx Pharmaceutic ... | Belloff Neil S. | General Counsel and ... | Option Exercise | A | 20.85 | 125,000 | 2,606,250 | 125,000 | |
| Jun 19 2018 | ELOX | Eloxx Pharmaceutic ... | Veinrib Gadi | Director | Option Exercise | A | 23.27 | 40,000 | 930,800 | 40,000 | |
| Jun 19 2018 | ELOX | Eloxx Pharmaceutic ... | Seehra Jasbir | Director | Option Exercise | A | 23.27 | 40,000 | 930,800 | 40,000 | |
| Jun 19 2018 | ELOX | Eloxx Pharmaceutic ... | Rubin Steven D | Director | Option Exercise | A | 23.27 | 40,000 | 930,800 | 40,000 | |
| Jun 19 2018 | ELOX | Eloxx Pharmaceutic ... | Pontifax Management III G.P. ( ... | 10% Owner | Option Exercise | A | 23.27 | 40,000 | 930,800 | 40,000 | |
| Jun 19 2018 | ELOX | Eloxx Pharmaceutic ... | Pontifax Management III G.P. ( ... | 10% Owner | Option Exercise | A | 23.27 | 40,000 | 930,800 | 40,000 | |
| Jun 19 2018 | ELOX | Eloxx Pharmaceutic ... | Pontifax Management 4 G.P. (20 ... | 10% Owner | Option Exercise | A | 23.27 | 40,000 | 930,800 | 40,000 | |
| Jun 19 2018 | ELOX | Eloxx Pharmaceutic ... | Pontifax Management 4 G.P. (20 ... | 10% Owner | Option Exercise | A | 23.27 | 40,000 | 930,800 | 40,000 | |
| Jun 19 2018 | ELOX | Eloxx Pharmaceutic ... | Nussbaum Ran | Director | Option Exercise | A | 23.27 | 40,000 | 930,800 | 40,000 | |
| Jun 19 2018 | ELOX | Eloxx Pharmaceutic ... | Noiman Silvia | Chief Executive Off ... | Option Exercise | A | 23.27 | 40,000 | 930,800 | 40,000 | |
| Jun 19 2018 | ELOX | Eloxx Pharmaceutic ... | Noiman Silvia | Chief Executive Off ... | Option Exercise | A | 23.27 | 141,389 | 3,290,122 | 141,389 | |
| Jun 19 2018 | ELOX | Eloxx Pharmaceutic ... | Noiman Silvia | Chief Executive Off ... | Grant | A | 0.00 | 141,389 | 0 | 141,389 | 0 to 141.4 K |
| Jun 19 2018 | ELOX | Eloxx Pharmaceutic ... | Kleijwegt Martijn | Director | Option Exercise | A | 23.27 | 40,000 | 930,800 | 40,000 | |
| Jun 19 2018 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Option Exercise | A | 23.27 | 40,000 | 930,800 | 40,000 | |
| Jun 19 2018 | ELOX | Eloxx Pharmaceutic ... | Avnur Zafrira | Director | Option Exercise | A | 23.27 | 40,000 | 930,800 | 40,000 | |
| Jun 19 2018 | ELOX | Eloxx Pharmaceutic ... | Avnur Zafrira | Director | Option Exercise | A | 23.27 | 40,000 | 930,800 | 40,000 |